Moreover, the expression level of SOX9 and nuclear translocation of TPI1 and PKM2 were higher in recurrent TMZ‐treated GBM tissues than in newly diagnosed GBM tissues (Figure S15, Supporting Information). This evidence concerns the gene SOX9 and glioblastoma.